A1 Refereed original research article in a scientific journal

Development of otology specific outcome measure: Ear Outcome Survey-16 (EOS-16)




AuthorsLaakso Juha T., Silvola Juha, Hirvonen Timo, Suutarla Samuli, Kivekäs Ilkka, Saarinen Riitta, Haavisto Lotta, Laitakari Jaakko, Aarnisalo Antti A., Dietz Aarno, Jero Jussi, Hytönen Maija, Sinkkonen Saku T.

PublisherPLA General Hospital Department of Otolaryngology Head and Neck Surgery

Publication year2021

JournalJournal of Otology

Journal name in sourceJournal of Otology

ISSN1672-2930

eISSN2524-1753

DOIhttps://doi.org/10.1016/j.joto.2021.01.003

Web address https://www.sciencedirect.com/science/article/pii/S1672293021000039?via=ihub

Self-archived copy’s web addresshttps://research.utu.fi/converis/portal/detail/Publication/53325317


Abstract

Purpose

An important outcome measure of patient care is the impact on the patient’s health-related quality of life (HRQoL). Current ear-specific HRQoL instruments are designed for one diagnosis and emphasize different subdivisions such as symptoms, hearing problems, psychosocial impact, and the need for care. The optimal length of the recall period has not been studied. For these reasons, a new survey is needed that would cover most chronic ear diseases.

Methods

A preliminary 24-item survey (EOS-24) was created. Untreated adult patients (included n = 186) with one of seven different chronic otologic conditions from all university hospitals in Finland were recruited to respond to EOS-24 and the 15D general HRQoL instrument. The recruiting otologists evaluated the severity of the disease and the disability caused by it. A control group was recruited. Based on the patients’ responses in different diagnosis groups, the items were reduced according to pre-defined criteria. The resulting survey was validated using a thorough statistical analysis.

Results

The relevance and necessity of the original 24 items were thoroughly investigated, leading to the exclusion of 8 items and the modification of 1. The remaining 16 items were well-balanced between subdivisions and were useful in all seven diagnosis groups, thus constituting the final instrument, EOS-16. The most suitable recall period was three months.

Conclusions

EOS-16 has been created according to the HRQoL survey guidelines with a versatile nationwide patient population. The survey has been validated and can be used for a wide range of chronic ear diseases as a HRQoL instrument.


Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 16:32